FDA Approves Takeda’s Eohilia, an Oral Treatment for Eosinophilic Esophagitis

Takeda expects Eohilia single-dose stick packs will be available by the end of February for patients aged 11 years and older with eosinophilic esophagitis.

Leave a Reply

Your email address will not be published. Required fields are marked *